Study of 4 drugs for advanced colorectal cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a combination of four drugs for people with advanced colorectal cancer who have already tried at least two other treatments. The goal is to see if this new mix can help shrink tumors or slow the cancer's growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced colorectal cancer that has spread or cannot be removed by surgery.
- You have already tried at least two standard treatments and they stopped working or caused side effects.
- You have at least one tumor that can be measured on a scan.
- You are 18 years or older and in generally good health (able to do daily activities).
- Your kidney and liver function must be within certain limits as shown on blood tests.
- You are not pregnant and agree to use birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of three drugs (irinotecan liposomes, cetuximab, and vemurafenib) for people with advanced colorectal cancer that has a specific genetic change (BRAF V600E mutation) and did not respond to first treatment. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.
This trial tests a combination of two drugs (cadonilimab and an anti-angiogenic agent) for advanced colorectal cancer that has a specific genetic feature (dMMR or MSI-H). It aims to find a new treatment option that might work better than current therapies.
This trial tests a combination of two oral medications for people with advanced colorectal cancer who cannot tolerate stronger chemotherapy. The goal is to see if this gentler approach slows tumor growth and improves quality of life.
This study tests a new combination of three drugs for advanced colorectal cancer that has not responded to standard treatments. The goal is to see if this combination can shrink tumors or slow down the cancer's growth.
This trial tests a combination of radiation therapy with three drugs (an immunotherapy, a chemotherapy pill, and a targeted therapy) for advanced colorectal cancer. It aims to see if this combination can shrink tumors and improve outcomes for people whose cancer has not responded to standard treatments.
This study tests a new combination of drugs and targeted radiation for people with advanced colorectal cancer that has spread to a few spots. It aims to see if this approach works better than the current standard treatment after other therapies have failed.
Hear when a new Advanced Colorectal Cancer in the Third-line Treatment and Beyond trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.